Patent US3280381A successfully refreshed from Google Patents.
Patent US2884290A successfully refreshed from Google Patents.
Patent EP0192327A2 successfully refreshed from Google Patents.
EP0192327A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Use of phosphonoformic acid and its esters and salts for the manufacture of a medicament for the treatment of AIDS
Assignee: Wellcome Foundation Ltd
•
Filing: 1986-01-17
•
Granted: —
•
Expires: 2006-01-17
Abstract
Abstract The present invention relates to the use of phosphono- formic acid, its esters and salts, in the treatment of acquired immune deficiency syndrome (AIDS).
Inventors
- 👤 Martha Heider St-Clair
- 👤 Phillip Allen Furman
- 👤 David Walter Barry
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-08 01:10
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/66; A61P; A61P37/00; A61P37/02; A61P37/04
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
98 words
I. Use of a compound of formula (I) (wherein R I , R2, and R 3 may be the some or different and each is selected from hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl, C 4-7 cycloalkyalkyl, benzyl and phenyl having up to three optional substituents selected from halogen, C 1-4 alkyl, C 1-4 alkoxy, C 2-7 alkoxycarbonyl and C 2-7 alkylcarbonyl and, when at least one of R 1 , R 2 and R 3 is hydrogen, pharmaceutically acceptable salts thereof) in the manufacture of a medicament for the treatment or prophylaxis of acquired immune deficiency syndrome.
Claim 2
Dependent Claim
25 words
Use of a compound of formula (I) as claimed in claim 1 wherein R 1 , R 2 , and R 3 each represent hydrogen.
Claim 3
Dependent Claim
30 words
Use of a pharmaceutically acceptable salt of a compound of formula (I) as claimed in claim I wherein R I , R 2 , and R 3 each represent hydrogen.
Claim 4
Dependent Claim
27 words
Use of a compound of formula (I) as claimed in any of claims I to 3 wherein the said salt is selected from mono, di- and triphosphate.
Claim 5
Dependent Claim
26 words
S. Use of a compound of formula (I) as claimed in any of claims 1 to 4 wherein the said medicament is adapted for intravenous administration.
Claim 6
Dependent Claim
29 words
Use of a compound of formula (I) as claimed in any of claims 1 to 4 wherein the said medicament is in the form of a tablet or capsule.
Claim 7
Dependent Claim
32 words
A compound of formula (I) or a pharmaceutically acceptable salt thereof (as defined in any of claims 1 to 4) for use in the treatment or prophylaxis of acquired immune deficiency syndrome.
Claim 8
Dependent Claim
35 words
A compound of formula (I) or a pharmaceutically acceptable salt thereof (as defined in any of claims I to 4) for use in the treatment or prophylaxis of an HTLV-III infection in a human being.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.